Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03418753 · ClinicalTrials.gov registry record
Non-invasive Diagnostic for Assessing Elevated Intracranial Pressure
A clinical trial, sponsored by Oculogica.
- Completed
- Registry status
- 60
- Enrollment target
NCT03418753: Completed study, sponsored by Oculogica.
NCT03418753 is a clinical trial that has completed, run by Oculogica. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03418753 has completed, sponsored by Oculogica.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The study is a prospective, multi-center, non-randomized, open label observational study. The objective of this study is to compare the accuracy of the EyeBOX to a clinical diagnosis of abnormal ICP as determined by an external ventriculostomy drain (EVD) or ventriculostomy catheter.
Primary Outcome
EyeBOX assessment of abnormal ICP relative to invasive intracranial pressure monitor
Interventions
- DIAGNOSTIC_TEST EyeBOX for ICP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-05-10 |
| Est. Completion | 2023-05-10 |
What the finished NCT03418753 record still lists
NCT03418753 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which EyeBOX for ICP is the first listed.
NCT03418753 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03418753 about?
NCT03418753 is a clinical study titled "Non-invasive Diagnostic for Assessing Elevated Intracranial Pressure". The study is a prospective, multi-center, non-randomized, open label observational study. The objective of this study is to compare the accuracy of the EyeBOX to a clinical diagnosis of abnormal ICP as determined by an external ventriculostomy drain (EVD) or ventriculostomy catheter.
What is the current status of trial NCT03418753?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2018-05-10. Estimated completion is 2023-05-10.
What interventions are being tested in trial NCT03418753?
The interventions under investigation include: EyeBOX for ICP (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03418753?
This trial is sponsored by Oculogica, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI